Postchemotherapy Retroperitoneal Lymph Node Dissection


  • Burak Çıtamak
  • Bülent Akdoğan
  • Mesut Altan
  • Haluk Özen

Received Date: 09.09.2014 Accepted Date: 10.09.2014 Bull Urooncol 2014;13(3):169-175

Post-chemotherapy retroperitoneal lymph node dissection contributes most important survival results to advanced testicular cancer, however it is one of the most challenging surgeries technically in Uro-oncology. Besides, it is critical not only for treatment but also for staging of testicular cancer. It diminishes the need for chemotherapy. Boundaries of resection (template) is always a debate; wide limits may cause better staging but high rates of retrograde ejaculation, modified templates may cause better quality of life but unresected metastasis in some patients. Minimally invasive approaches are reasonable for diagnosis, although inadequate when performed without chemotherapy for cure, so they should be performed in experienced centers only. (Bulletin of Urooncology 2014;13:169-175)

Keywords: Testicular cancer, RPLND, chemotherapy, PCRPLND

Full Text (Turkish)